Summary
The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Arterial Stenosis trial [SAMMPRIS; NCT00576693] found that treatment with aggressive medical management (AMM) was superior to AMM plus percutaneous transluminal angioplasty and stenting [Chimowitz MI et al. N Engl J Med 2011]. This article presents a detailed analysis of 30-day outcomes from the stenting arm of the SAMMPRIS trial.
- Neurology Clinical Trials
- Cerebrovascular Disease
- Interventional Techniques & Devices
- Thrombotic Disorders
- Interventional Radiology
- © 2012 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.